CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics platform company, today announced that management will present a company overview at the Canaccord Genuity 35th Annual Growth Conference held at the InterContinental Hotel in Boston, Mass. The presentation is scheduled for Thursday, August 13, 2015 at 3:00 p.m. (EDT).
Live audio webcast of the presentation will be available under the Investors and Media section of Seres’ website at www.serestherapeutics.com. A replay of the presentation will become available approximately one hour after the event and will be archived on the site for 14 days.
About Seres Therapeutics
Seres Therapeutics, Inc. is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome.